Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Single Ascending Dose Study of Intraperitoneal Triferic (Ferric Pyrophosphate Citrate) in Patients on Chronic Peritoneal Dialysis

Trial Profile

Single Ascending Dose Study of Intraperitoneal Triferic (Ferric Pyrophosphate Citrate) in Patients on Chronic Peritoneal Dialysis

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 16 Jan 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ferric pyrophosphate (Primary) ; Ferric pyrophosphate
  • Indications Iron deficiency anaemia
  • Focus Pharmacokinetics
  • Sponsors Rockwell Medical Technologies
  • Most Recent Events

    • 09 May 2019 According to a Rockwell Medical Technologies media release, data from this trial was presented at the 39th Annual Dialysis Conference in March 2019.
    • 18 Mar 2019 According to a Rockwell Medical Technologies media release, the data from two studies including this study will be presented at the Annual Dialysis Conference, the largest multi-disciplinary conference on dialysis Mar 16-19 2019.
    • 02 May 2018 According to a Rockwell Medical Technologies media release, data from this trial will be presented at the 17th Congress of the International Society for Peritoneal Dialysis (ISPD) 2018.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top